OMD, Osteomodulin (osteoadherin) is a KS‐SLRP that binds to osteoblasts via αVβ3 integrin and regulates osteogenesis through its interaction with BMP2. WNT1 transcriptionally activates the expression of OMD. This evidence concerns the gene WNT1 and occult macular dystrophy.